| HER2-Low Breast Cancer: Molecular Characteristics and Prognosis E Agostinetto, M Rediti, D Fimereli, V Debien, M Piccart, P Aftimos, ... Cancers 13 (11), 2824, 2021 | 178 | 2021 |
| Intratumor heterogeneity and clonal evolution in an aggressive papillary thyroid cancer and matched metastases S Le Pennec, T Konopka, D Gacquer, D Fimereli, M Tarabichi, G Tomás, ... Endocrine-related cancer 22 (2), 205-216, 2015 | 42 | 2015 |
| miRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancers M Saiselet, JM Pita, A Augenlicht, G Dom, M Tarabichi, D Fimereli, ... Oncotarget 7 (32), 52475, 2016 | 41 | 2016 |
| CW-PRED: a HMM-based method for the classification of cell wall-anchored proteins of Gram-positive bacteria DK Fimereli, KD Tsirigos, ZI Litou, TD Liakopoulos, PG Bagos, ... Hellenic Conference on Artificial Intelligence, 285-290, 2012 | 34 | 2012 |
| Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome D Venet, D Fimereli, F Rothé, B Boeckx, M Maetens, S Majjaj, G Rouas, ... EBioMedicine 56, 2020 | 33 | 2020 |
| G enomic hotspots but few recurrent fusion genes in breast cancer D Fimereli, D Fumagalli, D Brown, D Gacquer, F Rothé, R Salgado, ... Genes, Chromosomes and Cancer 57 (7), 331-338, 2018 | 23 | 2018 |
| No significant viral transcription detected in whole breast cancer transcriptomes D Fimereli, D Gacquer, D Fumagalli, R Salgado, F Rothé, D Larsimont, ... BMC cancer 15, 1-9, 2015 | 18 | 2015 |
| TriageTools: tools for partitioning and prioritizing analysis of high-throughput sequencing data D Fimereli, V Detours, T Konopka Nucleic acids research 41 (7), e86-e86, 2013 | 16 | 2013 |
| Timing evolution of lobular breast cancer through phylogenetic analysis D Fimereli, D Venet, M Rediti, B Boeckx, M Maetens, S Majjaj, G Rouas, ... Ebiomedicine 82, 2022 | 10 | 2022 |
| Artificial intelligence: Theories and applications DK Fimereli, KD Tsirigos, ZI Litou, TD Liakopoulos, PG Bagos, ... CW-PRED: A HMM-Based Method for the Classification of Cell Wall-Anchored …, 2012 | 7 | 2012 |
| HER2-low breast cancer: molecular characteristics and prognosis. Cancers (Basel). 2021 E Agostinetto, M Rediti, D Fimereli, V Debien, M Piccart, P Aftimos | 4 | |
| Characterization of the immune microenvironment in matched primary and metastatic breast cancer lesions from the AURORA study: BIG 14-01. F Hilbers, D Venet, E Agostinetto, M Benelli, A Guerrero, ... Journal of Clinical Oncology 41 (16_suppl), 1009-1009, 2023 | 3 | 2023 |
| Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial M Rediti, D Fimereli, M Mileva, Z Wimana, D Venet, P Flamen, T Guiot, ... Clinical Cancer Research 31 (1), 110-121, 2025 | 1 | 2025 |
| Abstract PS17-04: Clinical and Genomic Features of ER-Positive/HER2-negative Metastatic Breast Cancer in AURORA Molecular Screening Initiative (BIG 14-01): Mechanisms of … A Guerrero-Zotano, M Benelli, A Irrthum, D Cameron, L Ferrando, ... Cancer Research 84 (9_Supplement), PS17-04-PS17-04, 2024 | | 2024 |
| Abstract PO3-13-02: Genomic and intrinsic subtype correlates of serum thymidine kinase activity in patients with metastatic breast cancer treated with palbociclib and … S Tyekucheva, T Crestani, M Ignatiadis, P Neven, M Colleoni, S Henry, ... Cancer Research 84 (9_Supplement), PO3-13-02-PO3-13-02, 2024 | | 2024 |
| 10P PIK3CA mutation and response to neoadjuvant taselisib and endocrine therapy: A biomarker study of the LORELEI trial D Fimereli, PG Nuciforo, E de Azambuja, T Wilson, A Prat, M Filipits, ... ESMO Open 9, 2024 | | 2024 |
| Integrating spatial and single cell transcriptomics to identify and characterize biologically driven subgroups in invasive lobular carcinoma M Serra, A Papagiannis, M Rediti, F Lifrange, N Occelli, L Collet, ... European Journal of Cancer 200, 2024 | | 2024 |
| Unravelling tumor heterogeneity in patients with HER2-low hormone receptor-positive breast cancer using spatial transcriptomics D Fimereli, M Serra, M Rediti, F Lifrange, N Occelli, L Collet, D Vincent, ... European Journal of Cancer 200, 2024 | | 2024 |
| Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer I Assaf, D Fimereli, G Anthoine, R Fazio, V Daprà, A Audisio, A Bardiaux, ... Cancers 15 (24), 5823, 2023 | | 2023 |
| Unravelling spatial tumor organization and heterogeneity in lobular breast cancer using spatial transcriptomics L Collet, M Serra, M Rediti, F Lifrange, D Venet, XX Wang, D Vincent, ... CANCER RESEARCH 82 (4), 2022 | | 2022 |
Christos SotiriouUniversité Libre de BruxellesVerified email at bordet.be
